Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. (Q44188484)
scientific article published on 21 February 2013
Language:
Current Data About Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.
(P31) (Q13442814)
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P50) (Q42574068)
(P1545) 6
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(Q37611826)
(P1545) 7
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(Q40971068)
(P1545) 8
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(Q61163903)
(P1545) 1
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(Q56383785)
(P1545) 2
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(Q57119101)
(P1545) 4
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P304) 1782-1785
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P407) (Q1860)

(P433) 8
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P478) 27
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P577) Thursday, February 21, 2013
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P921) (Q715347)

(Q418611)
(P887)

(P1433) (Q6534498)
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P1476) "Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia" (language: en)
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P2093) K A Becker
(P1545) 3
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

M Zoratti
(P1545) 5
(P248)
(P698) 23426166
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23426166%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, February 24, 2020

(P2860) (Q38291180)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q37597609)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q37956990)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q42254718)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q39746194)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q24652512)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q42790829)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q41035921)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q47999318)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q37660632)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q57974118)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q39927250)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

(Q34633213)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2013.56
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 21 February 2013

External Links
(P356) 10.1038/LEU.2013.56
(P698) 23426166
(P5875) 235681800